Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • belco_mc belco_mc Aug 16, 2012 8:40 AM Flag

    Why Eteplirsen is a real breakthrough- don't underestimate Pat and the parents

    For the last 10 years, or so, the only treatment available for DMD boys have been things like steroids and over the counter pills like CoQ10.

    They are mildly effective, if at all. More than anything, those treatments give the parents and boys a feeling that they are doing 'something' to try and combat the relentless decline of muscles and loss of ambulation.

    Eteplirsen is the most significant breakthrough therapy ever developed for these families. It is based on new and effective science, is safe, and is showing clinical benefits.

    Until now, parents have been living on the 'hope' for a treatment or cure. This drug is the first treatment that moves beyond 'hope.'

    There will be a groundswell from parents lobbying the FDA to make this drug available ASAP. They will not be content waiting another 2 years for a phase III as they watch their boys decline.

    I believe the odds of an accelerated approval are much higher than people believe. Pat has gotten sophisticated at navigating the FDA and she will be a real force in using the power of the parents and politicians to pressure the FDA for early approval.

    If that happens, the boys and families will benefit greatly. And SRPT will be worth several billion dollars.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
24.66+0.04(+0.16%)Jul 28 4:00 PMEDT